𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir

✍ Scribed by Klára Grantz Šašková; Milan Kožíšek; Martin Lepšík; Jiří Brynda; Pavlína Řezáčová; Jana Václavíková; Ron M. Kagan; Ladislav Machala; Jan Konvalinka

Book ID
119824323
Publisher
Cold Spring Harbor Laboratory Press
Year
2008
Tongue
English
Weight
339 KB
Volume
17
Category
Article
ISSN
0961-8368

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chromatographic and Immunochemical Appro
Chromatographic and Immunochemical Approaches to the Analysis of the HIV Protease Inhibitor Saquinavir in Plasma
✍ H.R. Wiltshire; B.G. Wiltshire; A.F. Clarke; E. Worth; K.J. Prior; J.F. Tjia 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

The development of the HIV protease inhibitor saquinavir (Ro 31-8959) required a range of analytical methods for its measurement in biological fluids. This paper describes the development of isocratic, reversephase HPLC/UV methods for the routine measurement of plasma levels of the drug together wit

Management of drug-to-drug interactions
Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients
✍ Martin Vogel; Esther Voigt; Hans-Christoph Michaelis; Thomas Sudhop; Martin Wolf 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

Highly active antiretroviral therapy (HAART) has improved the life expectancy of HIV-infected patients, allowing orthotopic liver transplantation as a reasonable treatment option for selected patients with terminal liver disease. Both non-nucleoside reverse transcriptase inhibitors and protease inhi